Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Targeted treatment of solid tumors and hematologic malignancies.
KRAS wild-type Metastatic Colorectal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Non-Small Cell Lung Cancer.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Prevention and treatment of chemotherapy-induced febrile neutropenia and hematopoietic recovery.
Prevention and treatment of chemotherapy-induced febrile neutropenia and hematopoietic recovery.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Non-metastatic and metastatic Castration-Resistant and Castration-Sensitive Prostate Cancer.
Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) and Ph+ Acute Lymphoblastic Leukemia (ALL).
Non-metastatic and metastatic Castration-Resistant and Castration-Sensitive Prostate Cancer.